Because we demonstrated that local CAdVEC injection led to IFN-γ induction in both preclinical (humanized mice) and clinical studies, and that IFN-γ induces PD-L1 expression on cancer cells (6), it is likely that tumor cells per site in human subjects also express PD-L1 after CAdVEC injection. The gene discussed is IFNG; the disease is cancer.